Literature DB >> 7021010

The basal plasma glucose: a simple relevant index of maturity-onset diabetes.

R R Holman, R C Turner.   

Abstract

The 'basal' plasma glucose, defined as the stable overnight concentration, has been assessed as an index of diabetes control by comparison with plasma glucose measurements during 24-h profiles in diet-treated maturity-onset diabetic patients and normal subjects. The basal plasma glucose correlated with the total (r=0.98) and incremental (r=0.86) glucose areas, as well as the 24-h M value (r=0.90). In mild diabetes the basal value was more abnormal than the incremental glucose area after meals, since 3 h after meals 'reactive hypoglycaemia' lowered the plasma glucose to less than the basal value. Thus diabetics with a raised basal glucose up to 8 mmol/l can have a normal 3-h post-prandial value. A raised basal plasma glucose provides similar diagnostic information to conventional oral glucose tolerance tests and provides an apposite measure of diabetes control. Diabetics who come up to a clinic, or who exercise whilst fasting, have fasting plasma glucose and insulin concentrations slightly higher than their overnight 'basal' levels, whereas there is little change in normal subjects. This higher 'stressed fasting' plasma glucose needs to be taken into account when assessing fasting plasma glucose values.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7021010     DOI: 10.1111/j.1365-2265.1981.tb00196.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  14 in total

1.  The Need to Calculate Target Glucose Levels When Measuring Changes in Insulin Sensitivity During Interventions for Individuals With Type 2 Diabetes.

Authors:  Nor Azlan Othman; Paul D Docherty; Jeremy D Krebs; Damon A Bell; J Geoffrey Chase
Journal:  J Diabetes Sci Technol       Date:  2018-01-02

2.  A moderate physiological dose of benzyl butyl phthalate exacerbates the high fat diet-induced diabesity in male mice.

Authors:  Jian Zhang; Catherine A Powell; Matthew K Kay; Min Hi Park; Sunitha Meruvu; Ravi Sonkar; Mahua Choudhury
Journal:  Toxicol Res (Camb)       Date:  2020-06-12       Impact factor: 3.524

3.  Insulin action and determinants of glycaemia in a rat model of type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  W S Pascoe; A B Jenkins; M Kusunoki; L H Storlien
Journal:  Diabetologia       Date:  1992-03       Impact factor: 10.122

4.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

5.  The difficult choice of treatment for poorly controlled maturity onset diabetes: tablets or insulin?

Authors:  I Peacock; R B Tattersall
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-30

6.  Human ultralente insulin.

Authors:  R R Holman; J Steemson; P Darling; W G Reeves; R C Turner
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-03

7.  Markers of glycemic control in the mouse: comparisons of 6-h- and overnight-fasted blood glucoses to Hb A1c.

Authors:  Byoung Geun Han; Chuan-Ming Hao; Elena E Tchekneva; Ying-Ying Wang; Chieh Allen Lee; Benyamin Ebrahim; Raymond C Harris; Timothy S Kern; David H Wasserman; Matthew D Breyer; Zhonghua Qi
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-07-29       Impact factor: 4.310

8.  Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia.

Authors:  J S Yudkin; R D Forrest; C A Jackson; A J Ryle; S Davie; B J Gould
Journal:  Diabetologia       Date:  1990-04       Impact factor: 10.122

9.  Hyperglycaemia is one correlate of deterioration in vibration sense during the 5 years after diagnosis of type 2 (non-insulin-dependent) diabetes.

Authors:  R M Hillson; T D Hockaday; D J Newton
Journal:  Diabetologia       Date:  1984-02       Impact factor: 10.122

10.  UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance.

Authors: 
Journal:  Diabetologia       Date:  1991-12       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.